Reply to thread

This is the next horizon in cancer treatment. Today targeted chemotherapy drugs using cloned antibodies (e.g., rituximab) are considered cutting edge treatments for leukemia and many other cancers. The clinical and field trials are still very recent. Yet..... in 5 years these methods will be already old-generation because the immuno-therapies described in the article will have made advances and will be treatments of choice. Too much to keep track of.